CORRELATION BETWEEN CUMULATIVE METHOTREXATE DOSE, METABOLIC SYNDROME AND HEPATIC FIBROSIS DETECTED BY FIBROSCAN IN PATIENTS RECEIVING METHOTREXATE IN RHEUMATOID ARTHRITIS IN COMPARISON WITH PSORIATIC ARTHRITIS

被引：0
|
作者：
Lertnawapan, R. [1 ]
Chonprasertsuk, S. [1 ]
Siramolpiwat, S. [1 ]
Jatuworapruk., K. [1 ]
机构：
[1] Thammasat Univ, Fac Med, Internal Med, Pthumthani, Thailand
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
Comorbidities; Disease-modifying Drugs (DMARDs); Safety;
D O I：
10.1136/annrheumdis-2024-eular.2747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0590
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients
    Lertnawapan, Ratchaya
    Chonprasertsuk, Soonthorn
    Siramolpiwat, Sith
    Jatuworapruk, Kanon
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [2] Association between cumulative methotrexate dose and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate
    Sriram, P. B.
    Venkateswaran, A. R.
    Premkumar, K.
    Chezhian, A.
    Murali, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 239 - 239
  • [3] Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate
    Lertnawapan, Ratchaya
    Chonprasertsuk, Soonthorn
    Siramolpiwat, Sith
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (02) : 214 - 221
  • [4] ASSOCIATION BETWEEN CUMULATIVE METHOTREXATE DOSE, NON-INVASIVE SCORING SYSTEM AND HEPATIC FIBROSIS DETECTED BY FIBROSCAN IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING METHROTREXATE.
    Lertnawapan, R.
    Choanprasertsuk, S.
    Siramolpiwat, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 939 - 939
  • [5] SIGNIFICANT HEPATIC FIBROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS WAS NOT ASSOCIATED WITH DURATION OF TREATMENT OR CUMULATIVE DOSE OF METHOTREXATE
    Moghtaderi, Masoud
    Nazarinia, Mohammad Ali
    Shenavandeh, Saeedeh
    Aflaki, Elham
    Moini, Maryam
    HEPATOLOGY, 2023, 78 : S662 - S662
  • [6] Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis
    Lindsey Tilling
    Sue Townsend
    Joel David
    Clinical Drug Investigation, 2006, 26 : 55 - 62
  • [7] Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
    Tilling, L
    Townsend, S
    David, J
    CLINICAL DRUG INVESTIGATION, 2006, 26 (02) : 55 - 62
  • [8] Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis
    Lie, Elisabeth
    van der Heijde, Desiree
    Uhlig, Till
    Heiberg, Marte S.
    Koldingsnes, Wenche
    Rodevand, Erik
    Kaufmann, Cecilie
    Mikkelsen, Knut
    Kvien, Tore K.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 671 - 676
  • [9] The relationship between dose of methotrexate and incidence of liver fibrosis in patients with rheumatoid arthritis
    Akbarirad, Mina
    Rezaieyazdi, Zahra
    Tajik, Ali
    Ataei, Banafshe
    Sarabi, Mehrdad
    Mehradmajd, Hasan
    Vossoughinia, Hasan
    Firoozi, Abdollah
    REUMATOLOGIA, 2025, 63 (01): : 3 - 11
  • [10] Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis
    Arena, Umberto
    Stasi, Cristina
    Mannoni, Alessandro
    Benucci, Maurizio
    Maddali-Bongi, Susanna
    Cammelli, Daniele
    Assarat, Ali
    Marra, Fabio
    Pinzani, Massimo
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (02) : 149 - 153
12345